Potential panic disorder syndrome: Clinical and genetic linkage evidence

American Journal of Medical Genetics - Neuropsychiatric Genetics

Volumn 96, Issue 1, 2000, Pages 24-35

  Weissman, Myrna M ^a,b   Fyer, Abby J ^a   Haghighi, Fatemeh ^a   Heiman, Gary ^b   Deng, Zemin ^a   Hen, René ^b   Hodge, Susan E ^a,b   Knowles, James A ^a  

^a Columbia University ^*  (United States)

^b NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

Author keywords

Chromosome 13; Kidney bladder; Linkage; Medical symptoms; Mitral valve prolapse; Nocturnal enuresis; Panic disorder; Pleiotropic phenotypes; Serious headaches; Thyroid problems

Indexed keywords

ARTICLE; CHROMOSOME 13; FAMILY STUDY; GENETIC LINKAGE; HEADACHE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MITRAL VALVE PROLAPSE; NOCTURNAL ENURESIS; PANIC; PHENOTYPE; PRIORITY JOURNAL; SCHIZOPHRENIA; SYNDROME; THYROID DISEASE; URINARY TRACT DISEASE;

HUMANS; LINKAGE (GENETICS); PANIC DISORDER;

EID: 0034615188     PISSN: 15524841     EISSN: 1552485X     Source Type: Journal    
DOI: 10.1002/(SICI)1096-8628(20000207)96:1<24::AID-AJMG7>3.0.CO;2-E     Document Type: Article

References (93)

1. Adams P. 1994. LABMAN and LINKMAN: a data management system specifically designed for genome searches of complex diseases. Genet Epidemiol 11:87-98.
2. Blok BFM, Sturms LM, Holstage G. 1998. Brain activation during micturition in women. Brain 121:2033-2042.
3. Blouin J-L, Dombroski BA, Nath SK, Lasseter VK, Wolyniec PS, Nestadt G, Thornquist M, ullrich G, McGrath J, Kasch L, Lamacz M, Thomas MG, Gehrig C, Radhakrishna U, Snyder SE, Balk KG, Neufeld K, Swartz KL, DeMarchi N, Papadimitriou GN, Dikeos DG, Stefanis CN, Chakravarti A, Childs B, Housman DE, Kazazian HH, Antonarakis SE, Pulver AE. 1998. Schizophrenia susceptibility loci on chromosomes 13q32 and 8p21. Nat Genet 20:70-73, 1998.
4. Broman KW, Murray JC, Sheffield VC, White RL, Weber JL. 1998. Comprehensive human genetic maps: individual and sex-specific variation in recombination. Am J Hum Genet 63:861-869.
5. Brzustowicz LM, Honer WG, Chow EWC, Little D, Hogan J, Hodgkinson K, Bassett AS. 1999. Linkage of familial schizophrenia to chromosome 13q32. Am J Hum Genet 65:1096-1103.
6. Coplan JD, Papp LA, King DL, Gorman JM. 1992. Amelioration of mitral valve prolapse after treatment for panic disorder. Am J Psychiatry 149:1587-1588.
7. Coplan JD, Papp LA, Pine D, Martinez J, Cooper T, Rosenblum LA, Klein DF, Gorman JM. 1997. Clinical improvement with fluoxetine therapy and noradrengic function in patients with panic disorder. Arch Gen Psychiatry 54:643-648.
8. Coryell W. 1997. Hypersensitivity to carbon dioxide as disease-specific trait marker. Biological Psychiatry 41:259-263.
9. Cottingham RW Jr, Idury RM, Schaffer AA. 1993. Faster sequential genetic linkage computations. Am J Hum Genet 53:252-263.
10. Crowe RR, Pauls DL, Slymen DJ, Noyes R. 1980. A family study of anxiety neurosis: Morbidity risk in families of patients with and without mitral valve prolapse. Arch Gen Psychiatry 37:77-79.
11. Crowe RR, Gaffney G, Kerber R. 1982. Panic attacks in families with mitral valve prolapse. J Affect Disord 4:121-125.
12. Devinsky O, Sato S, Theodore WH, Porter RJ. 1989. Fear episodes due to limbic seizures with normal ictal scalp EEG: a subdural electrographic study. J Clin Psychiatry 50:28-30.
13. Edlund MJ, Swann AC, Clothier J. 1987. Patients with panic attacks and abnormal EEG results. Am J Psychiatry 144(4):508-509.
14. Eiberg H, Berendt I, Mohr J. 1995. Assignment of dominant inherited nocturnal enuresis (ENUR1) to chromosome 13q. Nat Genet 10:354-356.
15. Elbadawi A. 1997. Interstitial cystitis: a critique of current concepts with a new proposal for pathologic diagnosis and pathogenesis. Urology 49(Suppl 5A):14-40.
16. Fowler CJ. 1998. Brain activation during micturition. Brain 121(Pt 11): 2031-2032.
17. Frank E, Cassano GB, Shear MK, Rotondo A, Dell'Osso L, Mauri M, Maser J, Grochocinski V. 1998. The spectrum model: A more coherent approach to the complexity of psychiatric symptomatology. CNS Spectrums 3(4):23-34.
18. Friedman BH, Thayer JF. 1998. Autonomic balance revisited: Panic anxiety and heart rate variability. J Psychosom Res 44:133-151.
19. Fyer AJ, Weissman MM. 1999. Genetic linkage study of panic: Clinical methodology and description of pedigrees. Am J Med Genet (Neuropsychiatr Genet) 88:173-181.
20. Fyer AJ, Endicott J, Mannuzza S, Klein DF. 1985. Schedule for Affective Disorders and Schizophrenia-Lifetime Version, Modified for the study of Anxiety Disorders (SADS-LA). New York. Anxiety Disorders Clinic, New York Psychiatric Institute, (revised DSM IV, 1995).
21. Goddard AW, Charney DS. 1997. Toward an integrated neurobiology of panic disorder. J Clin Psychiatry 58Suppl 2:4-11.
22. Goodman AB. 1996. Congenital anomalies in relatives of schizophrenic probands may indicate a retinoid pathology. Schizophr Res 19:163-170.
23. Goodman AB. 1998. Three independent lines of evidence suggest retinoids as causal to schizophrenia. Proc Natl Acad Sci U S A 95:7240-7244.
24. Gorman JM, Fyer MR, Goetz R, Askanazi J, Martinez J, Liebowitz MR, Fyer AJ, Kinney J, Klein DF. 1987. Ventilatory physiology of patients with panic disorder. Arch Gen Psychiatry 45:31-39.
25. Gorman JM, Goetz RR, Fyer M, King DL, Fyer AJ, Liebowitz MR, Klein DF. 1988. The mitral valve prolapse-panic disorder connection. Psychosom Med 50(2):114-122.
26. Gorman JM, Papp LA, Coplan JD. 1995. Neuroanatomy and neurotransmitter function in panic disorder. In: Roose SP, Glick RA, editors. Anxiety as symptom and signal. Hillsdale, NJ: The Analytic Press. p 39-56.
27. Gorman JM, Browne ST, Papp LA, Martinez J, Welkowitz L, Coplan JD, Goetz RR, Kent J, Klein DF. 1997. Effects of antipanic treatment on response to carbon dioxide. Biol Psychiatry 42:982-991.
28. Gosling JA, Dixon JS, Lendon RG. 1977. The autonomic innervation of the human male and female bladder neck and proximal urethra. J Urol 118:302-305.
29. Gräsbeck A, Rorsman B, Hagnell O, Isberg PE. 1996. Mortality of anxiety syndrome in a normal population. The epidemiology of anxiety and depressive syndromes (V). Neuropsychobiology. 33:118-126.
30. Greenberg DA, Hodge SE, Vieland VJ, Spence MA. 1996. Affecteds-only linkage methods are not a panacea. Am J Hum Genet 58:892-895.
31. Greenberg DA, Abreu P, Hodge SE. 1998. The power to detect linkage in complex disease by means of simple LOD-score analyses. Am J Hum Genet 63:870-879.
32. Hamilton SP, Heiman GA, Haghighi F, Mick S, Klein DF, Hodge SE, Weissman MM, Fyer AJ, Knowles JA. 1999. Lack of genetic linkage or association between a functional serotonin transporter polymorphism and panic disorder. Psychiatric Genetics. 9:1-6.
33. Heninger GR. 1998. Catecholamines and pathogenesis in panic disorder (Commentary). Arch Gen Psychiatry 55:522-523.
34. Herdy GVH, Zabriskie JB, Chapman F, Khanna A, Swedo SE. 1992. A rapid test for the detection of a B-cell marker (D8/17) in rheumatic fever patients. Braz J Med Biol Res 25:789-794.
35. Hodge SE, Anderson CE, Neiswanger K, Sparkes RS, Rimoin DL. 1983. The search for heterogeneity in insulin-dependent diabetes mellitus (IDDM): linkage studies, two-locus models, and genetic heterogeneity. Am J Hum Genet 35:1139-1155.
36. Hodge SE, Abreu PC, Greenberg DA. 1997. Magnitude of type I error when single-locus linkage analysis is maximized over models: a simulation study. Am J Hum Genet 60:217-227.
37. Hoehn-Saric R, McLeod DR, Zimmerli WD. 1991. Psychophysiological response patterns to panic disorder. Acta Psychiatr Scand 83:4-11.
38. Holsboer F. 1999. The rationale for corticotropin-releasing hormone receptor (CRH-R) antagonists to treat depression and anxiety. J Psychiatr Res 33:181-214.
39. Holsboer F, Stalla GK, von Bardeleben U, Hammann K, Muller H, Muller OA. 1988. Acute adrenocortical stimulation by recombinant gamma interferon in human controls. Life Sci 42:1-5.
40. Jasmin L, Janni G, Manz HJ, Rabkin SD. 1998. Activation of CNS circuits producing a neurogenic cystitis: evidence for centrally induced peripheral inflammation. J Neurosci 18:10016-10029.
41. Kendler KS, Neale MC, Kessler RC, Heath AC, Eaves LJ: Panic disorder in women: a population-based twin study. Psychol Med 23:397-406, 1993.
42. Klein DF. 1993. False suffocation alarms, spontaneous attacks, and related conditions. Arch Gen Psychiatry 50:306-317.
43. Knowles AJ, Weissman MM. 1995. Panic disorder and agoraphobia. Psychiatric genetics. Section III. In: Oldham JM, Riba M, editors. Review of Psychiatry. Vol. 14. Washington DC: American Psychiatric Press, Inc. Chap 15, p 383-404.
44. Knowles JA, Vieland VJ, Gilliam TC. 1992. Perils of gene mapping with microsatellite markers. Am J Hum Genet 51:905-909.
45. Knowles JA, Fyer AJ, Vieland VJ, Weissman MM, Hodge SE. Heiman GA, Haghighi F, De Jesus GM, Rassnick H, Preud'homme-Rivelli X, Austin T, Cunjak J, Mick S, Fine JD, Woodley KA, Das K, Maier W Adams PB, Freimer NB, Klein DF, Gilliam TC. 1998. Results of a genome-wide genetic screen for panic disorder. Am J Med Genet ( Neuropsychiatr Genet) 81:139-147.
46. Leckman JF, Sholomskas D, Thompson WD, Belanger A, Weissman MM. 1982. Best Estimate of lifetime diagnosis: a methodologic study. Arch Gen Psychiatry 39:879-883.
47. LeDoux J. 1996. The emotional brain: the mysterious underpinning of the emotional life. New York: Simon and Schuster.
48. Lydiard R, Greenwald S, Weissman MM, Johnson J, Drossman D, Ballenger J. 1994. Panic disorder and gastrointestinal symptoms: findings from the NIMH Epidemiologic Catchment Area Project. Am J Psychiatry 151:64-70.
49. Magnuson VL, Ally DS, Nylund SJ, Karanjawala ZE, Rayman JB, Knapp JI, Lowe AL, Ghosh S, Collins FS. 1996. Substrate nucleotide-determined non-templated addition of adenine by Taq DNA polymerase: implications for PCR-based genotyping and cloning. Biotechniques 21:700-709.
50. Mahtani MM, Widen E, Lehto M, Thomas J, McCarthy M, Brayer J, Bryant B, Chan G, Daly M, Forsblom C, Kanninen T, Kirby A, Kruglyak L, Munnelly K, Parkkonen M, Reeve-Daly MP, Weaver A, Brettin T, Duyk G, Lander ES, Group LC. 1996. Mapping of a gene for type 2 diabetes associated with an insulin secretion defect by a genome scan in Finnish families. Nature Genet 14:90-95.
51. Mannuzza S, Fyer AJ, Klein DF. 1985. SADS-LA Family Informant Schedule and Criteria (FISC). New York: Anxiety Disorders Clinic, New York State Psychiatric Institute.
52. Mannuzza S, Fyer AJ, Klein DF, Endiccott J. 1986. Schedule for affective disorders and schizophrenia-lifetime version (modified for the study of anxiety disorders): rationale and conceptual development. J Psychiatr Res 20:317-325.
53. Maser JD, Cloninger RC, editors. 1990. Comorbidity of mood, anxiety disorders. Washington DC: American Psychiatric Press.
54. Mason I. 1996. The GDNF receptor: recent progress and unanswered questions. Mol Cell Neurosci 8:112-119.
55. Miniati M, Mauri M, Dell'Osso L, Pini S, Mengali F, Shear K, Maser J, Grochocinski V, Frank E, Cassano GB. 1998. Panic-agoraphobic spectrum and cardiovascular disease. CNS Spectrums 3(4):58-62.
56. Monnikes J, Heymann-Monnikes I, Tache Y. 1992. CRF in the paraventricular necleus of the hypothalamus induces dose-related behavioral profile in rats. Brain Res 574:70-76.
57. Morton NE. 1956. The detection and estimation of linkage between the genes for elliptocytosis and the Rh blood type. Am J Hum Genet 8:80-96.
58. st Century. Biol Psychiatry 44:517-525.
59. Neugebauer R, Weissman MM, Ouellette R, Johnson J, Markowitz J. 1993. Comorbidity of panic disorder and seizures: affinity or artifact? J Anxiety Disord 7:21-35.
60. Olpe H-R, Steinmann MN. 1991. Responses of locus coeruleus neurons to neuropeptides. Prog Brain Res 88:241-248.
61. Orvaschel H, Puig-Antich J, Chambers W, Tabrzi MA, Johnson R. 1982. Retrospective assessment of prepubertal major depression with the Kiddie-SADS-E. J Am Acad Child Adoles Psychiatry 21:392-397.
62. Ott J. 1983. Linkage analysis and family classification under heterogeneity. Ann Hum Genet 47:311-320.
63. Ott J 1991. Analysis of human genetic linkage. Revised edition. Baltimore: Hopkins.
64. Owens MJ, Nemeroff. 1993. The role of corticotropin-releasing factor in the pathophysiology of affective and anxiety disorders: laboratory and clinical studies. Ciba Found Symp 172:296-316.
65. Owens MJ, Vargas A, Nemeroff CB. 1993. The effects of alprazolam on corticotropin-releasing factor neurons in the rat brain: implications for a role for CRF in the pathogenesis of anxiety disorders. J Psychiatr Res 27 Suppl 1:209-220.
66. Papp LA, Martinez JM, Klein DF, Coplan JD, Norman R, Cole R, Gorman JM. 1997. Respiratory psychophysiology of panic disorder: Three respiratory challenges in 98 subjects. Am J Psychiatry 154(11):1557-1565.
67. Pavcovich LA, Valentino RJ. 1995. Central regulation of micturition in the rat by corticotropin-releasing hormone from Barrington's nucleus. Neurosci Lett 196:185-188.
68. 2 in healthy first-degree relatives of patients with panic disorder. Am J Psychiatry 152:623-625.
69. 2 in patients with panic disorder. Am J Psychiatry 153:1060-1064.
70. Roy-Bryne PP, Uhde TW, Post RM, Gallucci W, Chrousos GP, Gold PW. 1986. The corticoptropin-releasing hormone stimulation test in patients with panic disorder. Am J Psychiatry 143:896-899.
71. Sambrook J, Fritsch EF, Maniatis T. 1989. Molecular cloning, a laboratory manual. New York: Cold Spring Harbor Press.
72. Schaffer AA, Gupta SK, Shriram K, Cottingham RW Jr. 1994. Avoiding recomputation in linkage analysis. Hum Hered 44:225-237.
73. Stewart W, Breslau N, Keck PE. 1994. Comorbidity of migraine and panic disorder. Neurology 44(suppl 7):S23-S27.
74. Swedo SE, Leonard HL, Mittleman BB, Allen AJ, Rapoport JL, Dow SP, Kanter ME, Chapman F, Zacriskie J. 1997. Identification of children with pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections by a marker associated with rheumatic fever. Am J Psychiatry 154:110-112.
75. Swedo SE, Leonard HL, Garvey M, Mittleman B, Allen AJ, Perlmutter S, Dow S, Zamkoff J, Dubbert BK, Lougee L. 1998. Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections: clinical descriptions of the first 50 cases. Am J Psychiatry 155:264-271.
76. Swerdlow NR, Geyer MA, Vale WW, Koob GF. 1986. Corticotropin-releasing factor potentiates acoustic startle in rats: Blockade by chlordiazepoxide. Psychopharmacology 88:147-152.
77. Swift RG, Polymeropoulos MH, Torres R, Swift M. 1998. Predisposition of Wolfram Syndrome heterozygates to psychiatric illness. Molecular Psychiatry 3:86-91.
78. Terwilliger JD. 1997. ANALYZE computer program. ANALYZE(2.1). ftp:// linkage.cpmc.columbia.edu/software/analyze, J. Terwilliger. (GE-NERIC) Ref Type: Computer Program.
79. Theoharides TC. 1996. The mast cell: a neuroimmunoendocrine master player. Int J Tiss React 18:1-21.
80. Torgersen S: Genetic factors in anxiety disorders. Arch Gen Psychiatry 40:1085-1089, 1983.
81. Valentino RJ, Chen S, Zhu Y, Aston-Jones G. 1996. Evidence for divergent projections to the brain noradrenergic system and the spinal parasympathetic system from Barrington's nucleus. Brain Res 732:1-15.
82. Van Heyningen V. 1994. Genetics. One gene-four syndromes [news; comments]. Nature 367:319-320.
83. Vieland VJ, Hodge SE, Lish JD, Adams P, Weissman MM. 1993. Segregation analysis of panic disorder. Psychiatr Genet 3:63-71.
84. Vieland VJ, Goodman DW, Chapman T, Fyer AJ. 1996. A new segregation analysis of panic disorder. Am J Med Genet (Neuropsychiatry Genet) 67:147-153.
85. Von Bardeleben U, Holsboer F. 1988. Human corticotropin releasing hormone: clinical studies in patients with affective disorders, alcoholism, panic disorder and in normal controls. Prog Neuropsychopharmacol Biol Psychiatry 12:S165-S187.
86. Weilburg JB, Bear DM, Sachs G. 1987. Three patients with concomitant panic attacks and seizure disorder: Possible clues to the neurology of anxiety. Am J Psychiatry 144(8):1053-1056.
87. Weiss JM, Stout JC, Aaron MF, Quan N, Owens MJ, Butler PD, Nemeroff, CB. 1994. Depression and anxiety: role of locus coeruleus and corticotropin-releasing factor. Brain Res Bull 35:561-572.
88. Weissman MM, Markowitz J, Ouellette R, Greenwald S, Kahn P. 1990. Panic disorder and cardiovascular/cerebrovascular problems: Results from a community survey. Am J Psychiatry 147:1504-1508.
89. Weissman MM, Bland RC, Canino GJ, Faravelli C, Greenwald S, Hwu HG, Joyce PR, Karam EG, Lee CK, Lellouch J, Lepine JP, Newman SC, Oakley-Browne MA, Rubio-stipec M, Wells JE, Wickramaratne PJ, Wittchen HU, Yeh, EK. 1997. The cross national epidemiology of panic disorder. Arch Gen Psychiatry 54:305-309.
90. Welch KMA. 1997. Pathogenesis of migraine. Semin Neurol 17:335-341.
91. Wexler NS, Young AB, Tanzi RE, Travers H, Starosta-Rubinstgein S, Penney JB, Snodgrass SR, Shoulson I, Gomez F, Ramos Arroyo MA, Penchaszadeh GK, Moreno H, Gibbons K, Faryniarz A, Hobbs W, Anderson MA, Bonilla E, Conneally PM, Gusella JF. 1987. Homozygotes for Huntington's disease. Nature 326:194-197.
92. Wilkinson DJC, Thompson JM, Lambert GW, Jennings GL, Schwarz RG, Jefferys D, Turner AG, Esler MD. 1998. Sympathetic activity in patients with panic disorder at rest under laboratory mental stress and during panic attacks. Arch Gen Psychiatry 55:511-520.
93. Zigelman M, Appel S, Davidovtich S, Kurtzky A, Zahavi I, Akselrod S. 1994. The effect of verapamil calcium antagonist on autonomic imbalance in migraine: evaluation by spectral analysis of beat-to-beat heart rate fluctuations. Headache 34:569-577.